These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34441339)

  • 1. Promoter Hypermethylation of Tumor Suppressor Genes Located on Short Arm of the Chromosome 3 as Potential Biomarker for the Diagnosis of Nasopharyngeal Carcinoma.
    Lao TD; Nguyen TN; Le TAH
    Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
    Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
    Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma.
    Tian F; Yip SP; Kwong DL; Lin Z; Yang Z; Wu VW
    Cancer Epidemiol; 2013 Oct; 37(5):708-13. PubMed ID: 23790641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Zhou W; Feng X; Li H; Wang L; Zhu B; Liu W; Zhao M; Yao K; Ren C
    Acta Biochim Biophys Sin (Shanghai); 2009 Jan; 41(1):54-62. PubMed ID: 19129950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
    Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
    Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma.
    Chen J; Fu L; Zhang LY; Kwong DL; Yan L; Guan XY
    Chin J Cancer; 2012 May; 31(5):215-22. PubMed ID: 22360856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification.
    Ooft ML; van Ipenburg J; van Loo R; de Jong R; Moelans C; Braunius W; de Bree R; van Diest P; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
    J Clin Pathol; 2018 Apr; 71(4):351-359. PubMed ID: 28893862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients.
    Challouf S; Ziadi S; Zaghdoudi R; Ksiaa F; Ben Gacem R; Trimeche M
    Clin Chim Acta; 2012 Apr; 413(7-8):795-802. PubMed ID: 22296674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma.
    Li J; Zhou C; Wang G; Wang S; Ni S; Ye M; Zhang J
    Gene; 2018 Feb; 644():74-79. PubMed ID: 29107007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.
    Dai W; Cheung AK; Ko JM; Cheng Y; Zheng H; Ngan RK; Ng WT; Lee AW; Yau CC; Lee VH; Lung ML
    Cancer Med; 2015 Jul; 4(7):1079-90. PubMed ID: 25924914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma.
    Kwong J; Chow LS; Wong AY; Hung WK; Chung GT; To KF; Chan FL; Daigo Y; Nakamura Y; Huang DP; Lo KW
    Genes Chromosomes Cancer; 2007 Feb; 46(2):171-80. PubMed ID: 17099870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
    Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
    Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
    Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP
    Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma.
    Wong TS; Kwong DL; Sham JS; Tsao SW; Wei WI; Kwong YL; Yuen AP
    Clin Cancer Res; 2003 Aug; 9(8):3042-6. PubMed ID: 12912954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
    Li W; Li X; Wang W; Li X; Tan Y; Yi M; Yang J; McCarthy JB; Xiong W; Wu M; Ma J; Su B; Zhang Z; Liao Q; Xiang B; Li G
    Carcinogenesis; 2011 Sep; 32(9):1305-14. PubMed ID: 21803736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and Analysis of RNAs Expression Profile for Methylated Candidate Tumor Suppressor Genes in Nasopharyngeal Carcinoma.
    Zhao S; Zhang Y; Liang X; Li M; Peng F; Chen Z; Chen Y
    Anticancer Agents Med Chem; 2019; 19(6):772-782. PubMed ID: 30714531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.